Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Which Exchanges Will UnitedHealth Enter in 2021? Which Exchanges Will UnitedHealth Enter in 2021?
Blog July 9, 2020
Which Exchanges Will UnitedHealth Enter in 2021?
Celebrating 30 years of BioWorld Celebrating 30 years of BioWorld
Blog July 1, 2020
Celebrating 30 years of BioWorld
2019 trends in regulatory approvals of new medicines 2019 trends in regulatory approvals of new medicines
Blog June 19, 2020
2019 trends in regulatory approvals of new medicines
COVID-19 Complicates Value-Based Care COVID-19 Complicates Value-Based Care
Blog May 26, 2020
COVID-19 Complicates Value-Based Care
Drug discovery pipeline Drug discovery pipeline
Blog May 15, 2020
COVID-19 Brings Seismic Shifts to Future Healthcare Delivery
Applying regulatory flexibility in the age of COVID-19 Applying regulatory flexibility in the age of COVID-19
Blog May 15, 2020
Applying regulatory flexibility in the age of COVID-19
Biopharma customer engagement Biopharma customer engagement
Blog April 28, 2020
Key Disruptors in The Multiple Myeloma Landscape: 2020 and Beyond
Four NMEs Hope to Keep Up Momentum in the U.S. Migraine Market Four NMEs Hope to Keep Up Momentum in the U.S. Migraine Market
Blog April 17, 2020
Four NMEs Hope to Keep Up Momentum in the U.S. Migraine Market
Synergy Between AI and Digital Platforms for PBMs; Driving Value-Based Programs Synergy Between AI and Digital Platforms for PBMs; Driving Value-Based Programs
Blog April 13, 2020
Synergy Between AI and Digital Platforms for PBMs; Driving Value-Based Programs
The COVID-19 pandemic: European regulators respond The COVID-19 pandemic: European regulators respond
Blog April 7, 2020
The COVID-19 pandemic: European regulators respond